Karnataka bans coloured gobi manchurian, cotton candy over health concerns
Coloured gobi manchurian and cotton candy have been banned in Karnataka
Source: businesstoday.in
Page 3 - Sunset Yellow News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sunset Yellow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sunset Yellow Today - Breaking & Trending Today
HUTCHMED Announces that Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colorectal Cancer
— FRUZAQLA is the first targeted therapy approved in the U.S. for metastatic colorectal cancer regardless of biomarker status or prior types of therapies in more than a decade — — U.S....
Source: marketscreener.com
HUTCHMED Announces that Takeda Receives U.S. FDA Approval
— FRUZAQLA is the first targeted therapy approved in the U.S. for metastatic colorectal cancer regardless of biomarker status or prior types of therapies...
Source: globenewswire.com
Takeda Receives U.S. FDA Approval of FRUZAQLA™ (fruquintinib) for Previously Treated Metastatic Colo
− FRUZAQLA is the First Targeted Therapy Approved for Metastatic Colorectal Cancer (mCRC) Regardless of Biomarker Status or Prior Types of Therapies in More Than a Decade− FRUZAQLA Plus Best Supportive Care Demonstrated Significant Improvements in Overall Survival, with Corresponding Improvements in Progression Free...
Source: pharmiweb.com
Takeda Receives U.S. FDA Approval of FRUZAQLA fruquintinib for Previously Treated Metastatic Colorectal Cancer
Takeda TSE4502NYSETAK today announced that the U.S. Food and Drug Administration FDA has approved FRUZAQLA fruquintinib an oral targeted therapy for adults with metastatic colorectal cancer mCRC who have been previously treated with fluoropyrimidine oxaliplatin and irinotecanbased chemotherapy an antiVEGF therapy and if RAS wildtype and medically appropriate an antiEGFR therapy.
Source: businesswireindia.com